-
1
-
-
33750324311
-
The pathogenesis of rheumatoid arthritis
-
Weissmann G. The pathogenesis of rheumatoid arthritis. Bull NYU Hosp Jt Dis 2006, 64:12-15.
-
(2006)
Bull NYU Hosp Jt Dis
, vol.64
, pp. 12-15
-
-
Weissmann, G.1
-
2
-
-
76749117491
-
Immunologic rheumatic disorders
-
Joseph A, Brasington R, Kahl L, Ranganathan P, Cheng TP, Atkinson J. Immunologic rheumatic disorders. J Allergy Clin Immunol 2010, 125:204-215.
-
(2010)
J Allergy Clin Immunol
, vol.125
, pp. 204-215
-
-
Joseph, A.1
Brasington, R.2
Kahl, L.3
Ranganathan, P.4
Cheng, T.P.5
Atkinson, J.6
-
3
-
-
79956216108
-
Annual Drug Update 2010 in review
-
Belavic JM. Annual Drug Update 2010 in review. Nurse Pract 2011, 36:10-22.
-
(2011)
Nurse Pract
, vol.36
, pp. 10-22
-
-
Belavic, J.M.1
-
4
-
-
83255164819
-
Leflunomide or methotrexate? Comparison of clinical efficacy and safety in low socio-economic rheumatoid arthritis patients
-
10.1007/s10165-010-0405-4, 21229373
-
Ishaq M, Muhammad JS, Hameed K, Mirza AI. Leflunomide or methotrexate? Comparison of clinical efficacy and safety in low socio-economic rheumatoid arthritis patients. Mod Rheumatol 2011, 21:375-380. 10.1007/s10165-010-0405-4, 21229373.
-
(2011)
Mod Rheumatol
, vol.21
, pp. 375-380
-
-
Ishaq, M.1
Muhammad, J.S.2
Hameed, K.3
Mirza, A.I.4
-
5
-
-
75749141648
-
Updated consensus statement on biological agents for the treatment of rheumatic diseases
-
Furst DE, Keystone EC, Fleischmann R, Breedveld FC, Burmester GR, De Benedetti F, Dörner T, Emery P, Fleischmann R, Gibofsky A, Kalden JR, Kavanaugh A, Kirkham B, Mease P, Sieper J, Singer NG, Smolen JS, Van Riel PL, Weisman MH, Winthrop K. Updated consensus statement on biological agents for the treatment of rheumatic diseases. Ann Rheum Dis 2010, 69:2-29.
-
(2010)
Ann Rheum Dis
, vol.69
, pp. 2-29
-
-
Furst, D.E.1
Keystone, E.C.2
Fleischmann, R.3
Breedveld, F.C.4
Burmester, G.R.5
De Benedetti, F.6
Dörner, T.7
Emery, P.8
Fleischmann, R.9
Gibofsky, A.10
Kalden, J.R.11
Kavanaugh, A.12
Kirkham, B.13
Mease, P.14
Sieper, J.15
Singer, N.G.16
Smolen, J.S.17
Van Riel, P.L.18
Weisman, M.H.19
Winthrop, K.20
more..
-
6
-
-
79952362560
-
Disease activity score-driven therapy versus routine care in patients with recent-onset active rheumatoid arthritis: data from the GUEPARD trial and ESPOIR cohort
-
10.1136/ard.2010.137695, 3048626, 21242235
-
Soubrier M, Lukas C, Sibilia J, Fautrel B, Roux F, Gossec L, Patternotte S, Dougados M. Disease activity score-driven therapy versus routine care in patients with recent-onset active rheumatoid arthritis: data from the GUEPARD trial and ESPOIR cohort. Ann Rheum Dis 2011, 70:611-615. 10.1136/ard.2010.137695, 3048626, 21242235.
-
(2011)
Ann Rheum Dis
, vol.70
, pp. 611-615
-
-
Soubrier, M.1
Lukas, C.2
Sibilia, J.3
Fautrel, B.4
Roux, F.5
Gossec, L.6
Patternotte, S.7
Dougados, M.8
-
7
-
-
0028815803
-
Modified disease activity scores that include twenty eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis
-
10.1002/art.1780380107, 7818570
-
Prevoo ML, van't Hof MA, Kuper HH, van Leeuwen MA, van de Putte LB, van Riel PL. Modified disease activity scores that include twenty eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 1995, 38:44-48. 10.1002/art.1780380107, 7818570.
-
(1995)
Arthritis Rheum
, vol.38
, pp. 44-48
-
-
Prevoo, M.L.1
van't Hof, M.A.2
Kuper, H.H.3
van Leeuwen, M.A.4
van de Putte, L.B.5
van Riel, P.L.6
-
8
-
-
33750702536
-
Remission of rheumatoid arthritis: should we care about definitions?
-
Aletaha D, Smolen JS. Remission of rheumatoid arthritis: should we care about definitions?. Clin Exp Rheumatol 2006, 24:45-51.
-
(2006)
Clin Exp Rheumatol
, vol.24
, pp. 45-51
-
-
Aletaha, D.1
Smolen, J.S.2
-
9
-
-
35848963636
-
Updates on high throughput molecular profiling for the study of rheumatoid arthritis
-
10.1002/jcp.21258, 17786965
-
Goldring MB. Updates on high throughput molecular profiling for the study of rheumatoid arthritis. J Cell Physiol 2007, 213:626-634. 10.1002/jcp.21258, 17786965.
-
(2007)
J Cell Physiol
, vol.213
, pp. 626-634
-
-
Goldring, M.B.1
-
10
-
-
51849121176
-
The importance of reporting disease activity states in rheumatoid arthritis clinical trials
-
10.1002/art.23733, 18759299
-
Aletaha D, Funovits J, Smolen JS. The importance of reporting disease activity states in rheumatoid arthritis clinical trials. Arthritis Rheum 2008, 58:2622-2631. 10.1002/art.23733, 18759299.
-
(2008)
Arthritis Rheum
, vol.58
, pp. 2622-2631
-
-
Aletaha, D.1
Funovits, J.2
Smolen, J.S.3
-
11
-
-
75749152060
-
Up-regulation of cytokines and chemokines predates the onset of rheumatoid arthritis
-
Kokkonen H, Söderström I, Rocklöv J, Hallmans G, Lejon K, Rantapää Dahlqvist S. Up-regulation of cytokines and chemokines predates the onset of rheumatoid arthritis. Arthritis Rheum 2010, 62:383-391.
-
(2010)
Arthritis Rheum
, vol.62
, pp. 383-391
-
-
Kokkonen, H.1
Söderström, I.2
Rocklöv, J.3
Hallmans, G.4
Lejon, K.5
Rantapää Dahlqvist, S.6
-
12
-
-
77952672784
-
Role for interleukin-6 in structural joint damage and systemic bone loss in rheumatoid arthritis
-
10.1016/j.jbspin.2010.03.002, 20444632
-
Le Goff B, Blanchard F, Berthelot JM, Heymann D, Maugars Y. Role for interleukin-6 in structural joint damage and systemic bone loss in rheumatoid arthritis. Joint Bone Spine 2010, 77:201-205. 10.1016/j.jbspin.2010.03.002, 20444632.
-
(2010)
Joint Bone Spine
, vol.77
, pp. 201-205
-
-
Le Goff, B.1
Blanchard, F.2
Berthelot, J.M.3
Heymann, D.4
Maugars, Y.5
-
13
-
-
0008741084
-
Matrix metalloproteinases and tissue inhibitors of metalloproteinases in synovial fluids from patients with rheumatoid arthritis or osteoarthritis
-
10.1136/ard.59.6.455, 1753174, 10834863
-
Yoshihara Y, Nakamura H, Obata K, Yamada H, Hayakawa T, Fujikawa K, Okada Y. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in synovial fluids from patients with rheumatoid arthritis or osteoarthritis. Ann Rheum Dis 2000, 59:455-461. 10.1136/ard.59.6.455, 1753174, 10834863.
-
(2000)
Ann Rheum Dis
, vol.59
, pp. 455-461
-
-
Yoshihara, Y.1
Nakamura, H.2
Obata, K.3
Yamada, H.4
Hayakawa, T.5
Fujikawa, K.6
Okada, Y.7
-
14
-
-
0036839137
-
Invasive properties of fibroblast-like synoviocytes: correlation with growth characteristics and expression of MMP-1, MMP-3, and MMP-10
-
10.1136/ard.61.11.975, 1753950, 12379519
-
Tolboom TC, Pieterman E, van der Laan WH, Toes RE, Huidekoper AL, Nelissen RG, Breedveld FC, Huizinga TW. Invasive properties of fibroblast-like synoviocytes: correlation with growth characteristics and expression of MMP-1, MMP-3, and MMP-10. Ann Rheum Dis 2002, 61:975-980. 10.1136/ard.61.11.975, 1753950, 12379519.
-
(2002)
Ann Rheum Dis
, vol.61
, pp. 975-980
-
-
Tolboom, T.C.1
Pieterman, E.2
van der Laan, W.H.3
Toes, R.E.4
Huidekoper, A.L.5
Nelissen, R.G.6
Breedveld, F.C.7
Huizinga, T.W.8
-
15
-
-
73649086578
-
Cordycepin inhibits TPA-induced matrix metalloproteinase-9 expression by suppressing the MAPK/AP-1 pathway in MCF-7 human breast cancer cells
-
Noh EM, Youn HJ, Jung SH, Han JH, Jeong YJ, Chung EY, Jung JY, Kim BS, Lee SH, Lee YR, Kim JS. Cordycepin inhibits TPA-induced matrix metalloproteinase-9 expression by suppressing the MAPK/AP-1 pathway in MCF-7 human breast cancer cells. Int J Mol Med 2010, 25:255-260.
-
(2010)
Int J Mol Med
, vol.25
, pp. 255-260
-
-
Noh, E.M.1
Youn, H.J.2
Jung, S.H.3
Han, J.H.4
Jeong, Y.J.5
Chung, E.Y.6
Jung, J.Y.7
Kim, B.S.8
Lee, S.H.9
Lee, Y.R.10
Kim, J.S.11
-
16
-
-
51049101334
-
Adenosine receptors: therapeutic aspects for inflammatory and immune diseases
-
10.1038/nrd2638, 2568887, 18758473
-
Haskò G, Linden J, Cronstein B, Pacher P. Adenosine receptors: therapeutic aspects for inflammatory and immune diseases. Nat Rev Drug Discov 2008, 7:759-770. 10.1038/nrd2638, 2568887, 18758473.
-
(2008)
Nat Rev Drug Discov
, vol.7
, pp. 759-770
-
-
Haskò, G.1
Linden, J.2
Cronstein, B.3
Pacher, P.4
-
17
-
-
78650528837
-
How does methotrexate suppress inflammation?
-
Cronstein B. How does methotrexate suppress inflammation?. Clin Exp Rheumatol 2010, 28:21-23.
-
(2010)
Clin Exp Rheumatol
, vol.28
, pp. 21-23
-
-
Cronstein, B.1
-
18
-
-
77956896083
-
Much ado about adenosine: adenosine synthesis and function in regulatory T cell biology
-
10.4049/jimmunol.1000108, 3036969, 20686167
-
Ernst PB, Garrison JC, Thompson LF. Much ado about adenosine: adenosine synthesis and function in regulatory T cell biology. J Immunol 2010, 185:1993-1998. 10.4049/jimmunol.1000108, 3036969, 20686167.
-
(2010)
J Immunol
, vol.185
, pp. 1993-1998
-
-
Ernst, P.B.1
Garrison, J.C.2
Thompson, L.F.3
-
19
-
-
70349303795
-
Adenosine receptors in wound healing, fibrosis and angiogenesis
-
10.1007/978-3-540-89615-9_13, 19639289
-
Feoktistov I, Biaggioni I, Cronstein BN. Adenosine receptors in wound healing, fibrosis and angiogenesis. Handb Exp Pharmacol 2009, 193:383-397. 10.1007/978-3-540-89615-9_13, 19639289.
-
(2009)
Handb Exp Pharmacol
, vol.193
, pp. 383-397
-
-
Feoktistov, I.1
Biaggioni, I.2
Cronstein, B.N.3
-
20
-
-
77957583328
-
Methylxanthines and inflammatory cells
-
10.1007/978-3-642-13443-2_18, 20859808
-
Haskó G, Cronstein B. Methylxanthines and inflammatory cells. Handb Exp Pharmacol 2011, 200:457-468. 10.1007/978-3-642-13443-2_18, 20859808.
-
(2011)
Handb Exp Pharmacol
, vol.200
, pp. 457-468
-
-
Haskó, G.1
Cronstein, B.2
-
21
-
-
70349314951
-
Adenosine receptors and cancer
-
10.1007/978-3-540-89615-9_14, 19639290
-
Fishman P, Bar-Yehuda S, Synowitz M, Powell JD, Klotz KN, Gessi S, Borea PA. Adenosine receptors and cancer. Handb Exp Pharmacol 2009, 193:399-441. 10.1007/978-3-540-89615-9_14, 19639290.
-
(2009)
Handb Exp Pharmacol
, vol.193
, pp. 399-441
-
-
Fishman, P.1
Bar-Yehuda, S.2
Synowitz, M.3
Powell, J.D.4
Klotz, K.N.5
Gessi, S.6
Borea, P.A.7
-
22
-
-
76149098862
-
A2A adenosine receptor overexpression and functionality, as well as TNF-α, correlate with motor symptoms in Parkinson's disease
-
10.1096/fj.09-141044, 19776336
-
Varani K, Vincenzi F, Tosi A, Gessi S, Casetta I, Granieri G, Fazio P, Leung E, MacLennan S, Granieri E, Borea PA. A2A adenosine receptor overexpression and functionality, as well as TNF-α, correlate with motor symptoms in Parkinson's disease. FASEB J 2010, 24:587-598. 10.1096/fj.09-141044, 19776336.
-
(2010)
FASEB J
, vol.24
, pp. 587-598
-
-
Varani, K.1
Vincenzi, F.2
Tosi, A.3
Gessi, S.4
Casetta, I.5
Granieri, G.6
Fazio, P.7
Leung, E.8
MacLennan, S.9
Granieri, E.10
Borea, P.A.11
-
23
-
-
27544446871
-
Pharmacological characterization of novel adenosine ligands in recombinant and native human A2B receptors
-
10.1016/j.bcp.2005.08.018, 16219300
-
Varani K, Gessi S, Merighi S, Vincenzi F, Cattabriga E, Benini A, Klotz KN, Baraldi PG, Tabrizi MA, Lennan SM, Leung E, Borea PA. Pharmacological characterization of novel adenosine ligands in recombinant and native human A2B receptors. Biochem Pharm 2005, 70:1601-1612. 10.1016/j.bcp.2005.08.018, 16219300.
-
(2005)
Biochem Pharm
, vol.70
, pp. 1601-1612
-
-
Varani, K.1
Gessi, S.2
Merighi, S.3
Vincenzi, F.4
Cattabriga, E.5
Benini, A.6
Klotz, K.N.7
Baraldi, P.G.8
Tabrizi, M.A.9
Lennan, S.M.10
Leung, E.11
Borea, P.A.12
-
24
-
-
79953210022
-
Adenosine receptors and cancer
-
10.1016/j.bbamem.2010.09.020, 20888788
-
Gessi S, Merighi S, Sacchetto V, Simioni C, Borea PA. Adenosine receptors and cancer. Biochim Biophys Acta 2011, 1808:1400-1412. 10.1016/j.bbamem.2010.09.020, 20888788.
-
(2011)
Biochim Biophys Acta
, vol.1808
, pp. 1400-1412
-
-
Gessi, S.1
Merighi, S.2
Sacchetto, V.3
Simioni, C.4
Borea, P.A.5
-
25
-
-
15844400481
-
Modulation of cytokine release by purine receptors in patients with rheumatoid arthritis
-
Forrest CM, Harman G, McMillan RB, Stoy N, Stone TW, Darlington LG. Modulation of cytokine release by purine receptors in patients with rheumatoid arthritis. Clin Exp Rheumatol 2005, 23:89-92.
-
(2005)
Clin Exp Rheumatol
, vol.23
, pp. 89-92
-
-
Forrest, C.M.1
Harman, G.2
McMillan, R.B.3
Stoy, N.4
Stone, T.W.5
Darlington, L.G.6
-
26
-
-
78650417131
-
The role of adenosine receptors in rheumatoid arthritis
-
10.1016/j.autrev.2010.07.019, 20691813
-
Varani K, Padovan M, Govoni M, Vincenzi F, Trotta F, Borea PA. The role of adenosine receptors in rheumatoid arthritis. Autoimmun Rev 2010, 10:61-64. 10.1016/j.autrev.2010.07.019, 20691813.
-
(2010)
Autoimmun Rev
, vol.10
, pp. 61-64
-
-
Varani, K.1
Padovan, M.2
Govoni, M.3
Vincenzi, F.4
Trotta, F.5
Borea, P.A.6
-
27
-
-
67649385777
-
The anti-inflammatory target A3 adenosine receptor is over-expressed in rheumatoid arthritis, psoriasis and Crohn's disease
-
10.1016/j.cellimm.2009.03.020, 19426966
-
Ochaion A, Bar-Yehuda S, Cohen S, Barer F, Patoka R, Amital H, Reitblat T, Reitblat A, Ophir J, Konfino I, Chowers Y, Ben-Horin S, Fishman P. The anti-inflammatory target A3 adenosine receptor is over-expressed in rheumatoid arthritis, psoriasis and Crohn's disease. Cell Immunol 2009, 258:115-122. 10.1016/j.cellimm.2009.03.020, 19426966.
-
(2009)
Cell Immunol
, vol.258
, pp. 115-122
-
-
Ochaion, A.1
Bar-Yehuda, S.2
Cohen, S.3
Barer, F.4
Patoka, R.5
Amital, H.6
Reitblat, T.7
Reitblat, A.8
Ophir, J.9
Konfino, I.10
Chowers, Y.11
Ben-Horin, S.12
Fishman, P.13
-
28
-
-
70349309936
-
A3 adenosine receptor: pharmacology and role in disease
-
10.1007/978-3-540-89615-9_10, 19639286
-
Borea PA, Gessi S, Bar-Yehuda S, Fishman P. A3 adenosine receptor: pharmacology and role in disease. Handb Exp Pharmacol 2009, 193:297-327. 10.1007/978-3-540-89615-9_10, 19639286.
-
(2009)
Handb Exp Pharmacol
, vol.193
, pp. 297-327
-
-
Borea, P.A.1
Gessi, S.2
Bar-Yehuda, S.3
Fishman, P.4
-
29
-
-
38149051473
-
Clinical evidence for utilization of the A3 adenosine receptor as a target to treat rheumatoid arthritis: data from a phase II clinical trial
-
Silverman MH, Strand V, Markovits D, Nahir M, Reitblat T, Molad Y, Rosner I, Rozenbaum M, Mader R, Adawi M, Caspi D, Tishler M, Langevitz P, Rubinow A, Friedman J, Green L, Tanay A, Ochaion A, Cohen S, Kerns WD, Cohn I, Fishman-Furman S, Farbstein M, Yehuda SB, Fishman P. Clinical evidence for utilization of the A3 adenosine receptor as a target to treat rheumatoid arthritis: data from a phase II clinical trial. J Rheumatol 2008, 35:41-48.
-
(2008)
J Rheumatol
, vol.35
, pp. 41-48
-
-
Silverman, M.H.1
Strand, V.2
Markovits, D.3
Nahir, M.4
Reitblat, T.5
Molad, Y.6
Rosner, I.7
Rozenbaum, M.8
Mader, R.9
Adawi, M.10
Caspi, D.11
Tishler, M.12
Langevitz, P.13
Rubinow, A.14
Friedman, J.15
Green, L.16
Tanay, A.17
Ochaion, A.18
Cohen, S.19
Kerns, W.D.20
Cohn, I.21
Fishman-Furman, S.22
Farbstein, M.23
Yehuda, S.B.24
Fishman, P.25
more..
-
30
-
-
70349773147
-
Normalization of A2A and A3 adenosine receptor up-regulation in rheumatoid arthritis patients by treatment with anti-tumor necrosis factor α but not methotrexate
-
10.1002/art.24794, 19790066
-
Varani K, Massara A, Vincenzi F, Tosi A, Padovan M, Trotta F, Borea PA. Normalization of A2A and A3 adenosine receptor up-regulation in rheumatoid arthritis patients by treatment with anti-tumor necrosis factor α but not methotrexate. Arthritis Rheum 2009, 60:2880-2891. 10.1002/art.24794, 19790066.
-
(2009)
Arthritis Rheum
, vol.60
, pp. 2880-2891
-
-
Varani, K.1
Massara, A.2
Vincenzi, F.3
Tosi, A.4
Padovan, M.5
Trotta, F.6
Borea, P.A.7
-
31
-
-
0023945481
-
The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis
-
10.1002/art.1780310302, 3358796
-
Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS, Medsger TA, Mitchell DM, Neustadt DH, Pinals RS, Shaller JG, Sharp JT, Wilder RL, Hunder GG. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988, 31:315-324. 10.1002/art.1780310302, 3358796.
-
(1988)
Arthritis Rheum
, vol.31
, pp. 315-324
-
-
Arnett, F.C.1
Edworthy, S.M.2
Bloch, D.A.3
McShane, D.J.4
Fries, J.F.5
Cooper, N.S.6
Healey, L.A.7
Kaplan, S.R.8
Liang, M.H.9
Luthra, H.S.10
Medsger, T.A.11
Mitchell, D.M.12
Neustadt, D.H.13
Pinals, R.S.14
Shaller, J.G.15
Sharp, J.T.16
Wilder, R.L.17
Hunder, G.G.18
-
32
-
-
0021046385
-
Assessment of patient satisfaction of patient satisfaction in activities of daily living using a modified Stanford Health Assessment Questionnaire
-
10.1002/art.1780261107, 6639693
-
Pincus T, Summery JA, Soraci SA, Wallston KA, Hummon NP. Assessment of patient satisfaction of patient satisfaction in activities of daily living using a modified Stanford Health Assessment Questionnaire. Arthritis Rheum 1983, 26:1346-1353. 10.1002/art.1780261107, 6639693.
-
(1983)
Arthritis Rheum
, vol.26
, pp. 1346-1353
-
-
Pincus, T.1
Summery, J.A.2
Soraci, S.A.3
Wallston, K.A.4
Hummon, N.P.5
-
33
-
-
0028815803
-
Modified disease activity scores that include twenty-eight-joint counts: development and validation in a prospective longitudinal study of patients with rheumatoid arthritis
-
10.1002/art.1780380107, 7818570
-
Prevoo ML, van't Hof MA, Kuper HH, van Leeuwen MA, van de Putte LB, van Riel PL. Modified disease activity scores that include twenty-eight-joint counts: development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 1995, 38:44-48. 10.1002/art.1780380107, 7818570.
-
(1995)
Arthritis Rheum
, vol.38
, pp. 44-48
-
-
Prevoo, M.L.1
van't Hof, M.A.2
Kuper, H.H.3
van Leeuwen, M.A.4
van de Putte, L.B.5
van Riel, P.L.6
-
34
-
-
67650507114
-
Imaging progression despite clinical remission in early rheumatoid arthritis patients after etanercept interruption
-
Laganà B, Picchianti Diamanti A, Ferlito C, Germano V, Migliore A, Cremona A, Argento G, David V, Salemi S, D'Amelio R. Imaging progression despite clinical remission in early rheumatoid arthritis patients after etanercept interruption. Int J Immunopathol Pharmacol 2009, 22:447-454.
-
(2009)
Int J Immunopathol Pharmacol
, vol.22
, pp. 447-454
-
-
Laganà, B.1
Picchianti Diamanti, A.2
Ferlito, C.3
Germano, V.4
Migliore, A.5
Cremona, A.6
Argento, G.7
David, V.8
Salemi, S.9
D'Amelio, R.10
-
35
-
-
37849184958
-
Methotrexate regulates the expression of glucocorticoid receptor alpha and beta isoforms in normal human peripheral mononuclear cells and human lymphocyte cell lines in vitro
-
10.1016/j.molimm.2006.07.303, 17118450
-
Goecke IA, Alvarez C, Henríquez J, Salas K, Molina ML, Ferreira A, Gatica H. Methotrexate regulates the expression of glucocorticoid receptor alpha and beta isoforms in normal human peripheral mononuclear cells and human lymphocyte cell lines in vitro. Mol Immunol 2007, 44:2115-2123. 10.1016/j.molimm.2006.07.303, 17118450.
-
(2007)
Mol Immunol
, vol.44
, pp. 2115-2123
-
-
Goecke, I.A.1
Alvarez, C.2
Henríquez, J.3
Salas, K.4
Molina, M.L.5
Ferreira, A.6
Gatica, H.7
-
36
-
-
79953331405
-
Interleukin 1 receptor antagonist mediates the beneficial effects of systemic interferon beta in mice: implications for rheumatoid arthritis
-
10.1136/ard.2010.141077, 21216819
-
Corr M, Boyle DL, Ronacher LM, Lew BR, van Baarsen LG, Tak PP, Firestein GS. Interleukin 1 receptor antagonist mediates the beneficial effects of systemic interferon beta in mice: implications for rheumatoid arthritis. Ann Rheum Dis 2011, 70:858-863. 10.1136/ard.2010.141077, 21216819.
-
(2011)
Ann Rheum Dis
, vol.70
, pp. 858-863
-
-
Corr, M.1
Boyle, D.L.2
Ronacher, L.M.3
Lew, B.R.4
van Baarsen, L.G.5
Tak, P.P.6
Firestein, G.S.7
-
37
-
-
79952359481
-
Mitochondrial DNA haplogroups and serum levels of proteolytic enzymes in patients with osteoarthritis
-
Rego-Pérez I, Fernández-Moreno M, Deberg M, Pértega S, Fernández-López C, Oreiro N, Henrotin Y, Blanco FJ. Mitochondrial DNA haplogroups and serum levels of proteolytic enzymes in patients with osteoarthritis. Ann Rheum Dis 2010, 70:646-652.
-
(2010)
Ann Rheum Dis
, vol.70
, pp. 646-652
-
-
Rego-Pérez, I.1
Fernández-Moreno, M.2
Deberg, M.3
Pértega, S.4
Fernández-López, C.5
Oreiro, N.6
Henrotin, Y.7
Blanco, F.J.8
-
38
-
-
0035477981
-
Inflammatory cytokines regulate function and expression of adenosine A(2A) receptors in human monocytic THP-1 cells
-
Khoa ND, Montesinos MC, Reiss AB, Delano D, Awadallah N, Cronstein BN. Inflammatory cytokines regulate function and expression of adenosine A(2A) receptors in human monocytic THP-1 cells. J Immunol 2001, 167:4026-4032.
-
(2001)
J Immunol
, vol.167
, pp. 4026-4032
-
-
Khoa, N.D.1
Montesinos, M.C.2
Reiss, A.B.3
Delano, D.4
Awadallah, N.5
Cronstein, B.N.6
-
39
-
-
0141923779
-
Th1 cytokines regulate adenosine receptors and their downstream signaling elements in human microvascular endothelial cells
-
Nguyen DK, Montesinos MC, Williams AJ, Kelly M, Cronstein BN. Th1 cytokines regulate adenosine receptors and their downstream signaling elements in human microvascular endothelial cells. J Immunol 2003, 171:3991-3998.
-
(2003)
J Immunol
, vol.171
, pp. 3991-3998
-
-
Nguyen, D.K.1
Montesinos, M.C.2
Williams, A.J.3
Kelly, M.4
Cronstein, B.N.5
-
40
-
-
33645100368
-
Tumor necrosis factor-alpha prevents desensitization of Galphas-coupled receptors by regulating GRK2 association with the plasma membrane
-
10.1124/mol.105.016857, 1534129, 16385076
-
Khoa ND, Postow M, Danielsson J, Cronstein BN. Tumor necrosis factor-alpha prevents desensitization of Galphas-coupled receptors by regulating GRK2 association with the plasma membrane. Mol Pharmacol 2006, 69:1311-1319. 10.1124/mol.105.016857, 1534129, 16385076.
-
(2006)
Mol Pharmacol
, vol.69
, pp. 1311-1319
-
-
Khoa, N.D.1
Postow, M.2
Danielsson, J.3
Cronstein, B.N.4
-
41
-
-
33846246044
-
Overexpression of A3 adenosine receptor in peripheral blood mononuclear cells in rheumatoid arthritis: involvement of nuclear factor-κB in mediating receptor level
-
Madi L, Cohen S, Ochayon A, Bar-Yehuda S, Barer F, Fishman P. Overexpression of A3 adenosine receptor in peripheral blood mononuclear cells in rheumatoid arthritis: involvement of nuclear factor-κB in mediating receptor level. J Rheumatol 2007, 34:20-26.
-
(2007)
J Rheumatol
, vol.34
, pp. 20-26
-
-
Madi, L.1
Cohen, S.2
Ochayon, A.3
Bar-Yehuda, S.4
Barer, F.5
Fishman, P.6
-
42
-
-
57049172430
-
Inhibition of IL-1beta-mediated inflammatory responses by the IkappaB alpha super-repressor in human fibroblast-like synoviocytes
-
10.1016/j.bbrc.2008.11.002, 19007749
-
Lee YR, Kweon SH, Kwon KB, Park JW, Yoon TR, Park BH. Inhibition of IL-1beta-mediated inflammatory responses by the IkappaB alpha super-repressor in human fibroblast-like synoviocytes. Biochem Biophys Res Commun 2009, 378:90-94. 10.1016/j.bbrc.2008.11.002, 19007749.
-
(2009)
Biochem Biophys Res Commun
, vol.378
, pp. 90-94
-
-
Lee, Y.R.1
Kweon, S.H.2
Kwon, K.B.3
Park, J.W.4
Yoon, T.R.5
Park, B.H.6
-
43
-
-
55849114042
-
Inhibition of interleukin-1beta-induced matrix metalloproteinases 1 and 13 production in human osteoarthritic chondrocytes by prostaglandin D2
-
10.1002/art.23958, 2657141, 18975308
-
Zayed N, Afif H, Chabane N, Mfuna-Endam L, Benderdour M, Martel-Pelletier J, Pelletier JP, Motiani RK, Trebak M, Duval N, Fahmi H. Inhibition of interleukin-1beta-induced matrix metalloproteinases 1 and 13 production in human osteoarthritic chondrocytes by prostaglandin D2. Arthritis Rheum 2008, 58:3530-3540. 10.1002/art.23958, 2657141, 18975308.
-
(2008)
Arthritis Rheum
, vol.58
, pp. 3530-3540
-
-
Zayed, N.1
Afif, H.2
Chabane, N.3
Mfuna-Endam, L.4
Benderdour, M.5
Martel-Pelletier, J.6
Pelletier, J.P.7
Motiani, R.K.8
Trebak, M.9
Duval, N.10
Fahmi, H.11
-
44
-
-
19944432267
-
Prevention of progressive joint destruction in collagen-induced arthritis in rats by a novel matrix metalloproteinase inhibitor, FR255031
-
1575983, 15644877
-
Ishikawa T, Nishigaki F, Miyata S, Hirayama Y, Minoura K, Imanishi J, Neya M, Mizutani T, Imamura Y, Naritomi Y, Murai H, Ohkubo Y, Kagayama A, Mutoh S. Prevention of progressive joint destruction in collagen-induced arthritis in rats by a novel matrix metalloproteinase inhibitor, FR255031. Br J Pharmacol 2005, 144:133-143. 1575983, 15644877.
-
(2005)
Br J Pharmacol
, vol.144
, pp. 133-143
-
-
Ishikawa, T.1
Nishigaki, F.2
Miyata, S.3
Hirayama, Y.4
Minoura, K.5
Imanishi, J.6
Neya, M.7
Mizutani, T.8
Imamura, Y.9
Naritomi, Y.10
Murai, H.11
Ohkubo, Y.12
Kagayama, A.13
Mutoh, S.14
-
45
-
-
51049101334
-
Adenosine receptors: therapeutic aspects for inflammatory and immune diseases
-
10.1038/nrd2638, 2568887, 18758473
-
Haskó G, Linden J, Cronstein B, Pacher P. Adenosine receptors: therapeutic aspects for inflammatory and immune diseases. Nat Rev Drug Discov 2008, 7:759-770. 10.1038/nrd2638, 2568887, 18758473.
-
(2008)
Nat Rev Drug Discov
, vol.7
, pp. 759-770
-
-
Haskó, G.1
Linden, J.2
Cronstein, B.3
Pacher, P.4
-
46
-
-
78651092071
-
Adenosine, inflammation pathways and therapeutic challenges
-
10.1016/j.jbspin.2010.08.010, 20889361
-
Csòka B, Haskò G. Adenosine, inflammation pathways and therapeutic challenges. Joint Bone Spine 2011, 78:4-6. 10.1016/j.jbspin.2010.08.010, 20889361.
-
(2011)
Joint Bone Spine
, vol.78
, pp. 4-6
-
-
Csòka, B.1
Haskò, G.2
-
47
-
-
33644765841
-
IL-32, a proinflammatory cytokine in rheumatoid arthritis
-
10.1073/pnas.0511233103, 1413916, 16492735
-
Joosten LA, Netea MG, Kim SH, Yoon DY, Oppers-Walgreen B, Radstake TR, Barrera P, van de Loo FA, Dinarello CA, van den Berg WB. IL-32, a proinflammatory cytokine in rheumatoid arthritis. Proc Natl Acad Sci USA 2006, 103:3298-3303. 10.1073/pnas.0511233103, 1413916, 16492735.
-
(2006)
Proc Natl Acad Sci USA
, vol.103
, pp. 3298-3303
-
-
Joosten, L.A.1
Netea, M.G.2
Kim, S.H.3
Yoon, D.Y.4
Oppers-Walgreen, B.5
Radstake, T.R.6
Barrera, P.7
van de Loo, F.A.8
Dinarello, C.A.9
van den Berg, W.B.10
-
48
-
-
77953536536
-
Interleukin-32gamma enhances the production of IL-6 and IL-8 in fibroblast-like synoviocytes via Erk1/2 activation
-
10.1007/s10875-009-9360-2, 20072851
-
Kim YG, Lee CK, Kim SH, Cho WS, Mun SH, Yoo B. Interleukin-32gamma enhances the production of IL-6 and IL-8 in fibroblast-like synoviocytes via Erk1/2 activation. J Clin Immunol 2010, 30:260-267. 10.1007/s10875-009-9360-2, 20072851.
-
(2010)
J Clin Immunol
, vol.30
, pp. 260-267
-
-
Kim, Y.G.1
Lee, C.K.2
Kim, S.H.3
Cho, W.S.4
Mun, S.H.5
Yoo, B.6
-
49
-
-
39049144388
-
Key regulatory molecules of cartilage destruction in rheumatoid arthritis: an in vitro study
-
10.1186/ar2358, 2374452, 18205922
-
Andreas K, Lübke C, Häupl T, Dehne T, Morawietz L, Ringe J, Kaps C, Sittinger M. Key regulatory molecules of cartilage destruction in rheumatoid arthritis: an in vitro study. Arthritis Res Ther 2008, 10:R9. 10.1186/ar2358, 2374452, 18205922.
-
(2008)
Arthritis Res Ther
, vol.10
-
-
Andreas, K.1
Lübke, C.2
Häupl, T.3
Dehne, T.4
Morawietz, L.5
Ringe, J.6
Kaps, C.7
Sittinger, M.8
-
50
-
-
0030804643
-
Posttranscriptional regulation of collagenase-1 gene expression in synoviocytes by adenosine receptor stimulation
-
10.1002/art.1780401008, 9336410
-
Boyle DL, Han Z, Rutter JL, Brinckerhoff CE, Firestein GS. Posttranscriptional regulation of collagenase-1 gene expression in synoviocytes by adenosine receptor stimulation. Arthritis Rheum 1997, 40:1772-1779. 10.1002/art.1780401008, 9336410.
-
(1997)
Arthritis Rheum
, vol.40
, pp. 1772-1779
-
-
Boyle, D.L.1
Han, Z.2
Rutter, J.L.3
Brinckerhoff, C.E.4
Firestein, G.S.5
-
51
-
-
77950307115
-
Treating rheumatoid arthritis to target: recommendations of an international task force
-
10.1136/ard.2009.123919, 3015099, 20215140, T2T Expert Committee
-
Smolen JS, Aletaha D, Bijlsma JWJ, Breedveld FC, Boumpas D, Burmester G, Combe B, Cutolo M, de Wit M, Dougados M, Emery P, Gibofsky A, Gomez-Reino JJ, Haraoui B, Kalden J, Keystone EC, Kvien TK, McInnes I, Martin-Mola E, Montecucco C, Schoels M, van der Heijde D, . T2T Expert Committee Treating rheumatoid arthritis to target: recommendations of an international task force. Ann Rheum Dis 2010, 69:631-637. 10.1136/ard.2009.123919, 3015099, 20215140, T2T Expert Committee.
-
(2010)
Ann Rheum Dis
, vol.69
, pp. 631-637
-
-
Smolen, J.S.1
Aletaha, D.2
Bijlsma, J.W.J.3
Breedveld, F.C.4
Boumpas, D.5
Burmester, G.6
Combe, B.7
Cutolo, M.8
de Wit, M.9
Dougados, M.10
Emery, P.11
Gibofsky, A.12
Gomez-Reino, J.J.13
Haraoui, B.14
Kalden, J.15
Keystone, E.C.16
Kvien, T.K.17
McInnes, I.18
Martin-Mola, E.19
Montecucco, C.20
Schoels, M.21
van der Heijde, D.22
more..
-
52
-
-
84863988003
-
Serum adenosine deaminase may predict disease activity in rheumatoid arthritis
-
Zamani B, Jamali R, Jamali A. Serum adenosine deaminase may predict disease activity in rheumatoid arthritis. Rheumatol Int 2011,
-
(2011)
Rheumatol Int
-
-
Zamani, B.1
Jamali, R.2
Jamali, A.3
|